Search | IOVS | ARVO Journals

Showing 1 – 20 of 21

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract July 2019

Taurocholic acid prevents progression of age-related macular degeneration in in vitro models

Joshua McAlister Barnett; Cassandra Warden; Milam A Brantley

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):375.

Retinal Cell Biology October 2014

Endoglin Promotes Angiogenesis in Cell- and Animal-Based Models of Retinal Neovascularization

PDF

Joshua M. Barnett; Sandra Suarez; Gary W. McCollum; John S. Penn
TAGS: angiogenesis, hypoxia, retinal neovascularization, rats, anti-vascular endothelial growth factor therapy, oxygen, neovascularization, pathologic, retinal diseases, immunohistochemistry, retina
Invest. Ophthalmol. Vis. Sci.. 2014; 55(10):6490-6498. https://doi.org/10.1167/iovs.14-14945

Includes: Supplemental Content

Research Highlight January 2013

Unlocking the Potential to Regenerate Lost Neurons and Visual Function

PDF

Joshua M. Barnett

Invest. Ophthalmol. Vis. Sci.. 2013; 54(1):454. https://doi.org/10.1167/iovs.12-11338

ARVO Annual Meeting Abstract March 2012

Blocking Endoglin Reduces Endothelial Progenitor Cell Angiogenic Capacity and Retinal Neovascularization

Joshua M. Barnett; Gary W. McCollum; John S. Penn

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):3018.

ARVO Annual Meeting Abstract April 2011

Tube Formation and Proliferative Capacities of Endothelial Progenitor Cell Subpopulations: a Systematic Analysis

Joshua M. Barnett; Ashwath Jayagopal; Gary W. McCollum; John S. Penn

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):3185.

ARVO Annual Meeting Abstract April 2011

Targeted Nanocarriers for Therapy of Ocular Neovascularization

Ashwath Jayagopal; Joshua M. Barnett; John S. Penn

Invest. Ophthalmol. Vis. Sci.. 2011; 52(14):4844.

ARVO Annual Meeting Abstract April 2010

In vitro Parallel Plate Flow Chamber Assessment of Endothelial Progenitor Cell Homing

J. M. Barnett; H. S. Toma; G. W. McCollum; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):2641.

ARVO Annual Meeting Abstract April 2010

Hyperglycemia Increases PGI2, VEGF and PPARβ/-Dependent Transcription in the Mouse Retina

G. W. McCollum; J. M. Barnett; R. Yang; M. E. Capozzi; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):5616.

ARVO Annual Meeting Abstract April 2010

Inhibition of Prostaglandins is Associated With Decreased Retinal VEGF Expression Levels in an Animal Model of AMD

H. S. Toma; J. M. Barnett; J. S. Penn; S. J. Kim

Invest. Ophthalmol. Vis. Sci.. 2010; 51(13):6153.

Retinal Cell Biology February 2010

Role of Cytosolic Phospholipase A 2 in Retinal Neovascularization

PDF

Joshua M. Barnett; Gary W. McCollum; John S. Penn
TAGS: cobra perilaryngeal airway, phospholipases a, retinal neovascularization, vascular endothelial growth factor a, cytosol, hypoxia
Invest. Ophthalmol. Vis. Sci.. 2010; 51(2):1136-1142. https://doi.org/10.1167/iovs.09-3691

Retinal Cell Biology November 2009

The Role of PGE 2 Receptor EP 4 in Pathologic Ocular Angiogenesis

PDF

Susan E. Yanni; Joshua M. Barnett; Monika L. Clark; John S. Penn
TAGS: angiogenesis, antagonists, vascular endothelial growth factor a
Invest. Ophthalmol. Vis. Sci.. 2009; 50(11):5479-5486. https://doi.org/10.1167/iovs.09-3652

ARVO Annual Meeting Abstract April 2009

A Validated Method of Analyzing Treatment Response of Choroidal Neovascularization using Adobe Photoshop

H. S. Toma; J. M. Barnett; S. J. Kim

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):1166.

ARVO Annual Meeting Abstract April 2009

Inhibition of Retinal Vascular Growth and Development in PPARβ-/- Mice

J. M. Barnett; G. W. McCollum; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2954.

ARVO Annual Meeting Abstract April 2009

Differential Gene Expression in Response to Penetrating Ocular Injury

W. Y. Boadi; G. W. McCollum; J. M. Barnett; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2009; 50(13):2956.

ARVO Annual Meeting Abstract May 2008

The Influence of Penetrating Ocular Injury on Laser-Induced Choroidal Neovascularization in the Rat

J. M. Barnett; G. W. McCollum; L. T. Jefferson; W. Y. Boadi; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):2625.

ARVO Annual Meeting Abstract May 2008

PGE2 Receptor EP4 Is a Potential Therapeutic Target for the Treatment of Pathological Ocular Angiogenesis

S. E. Yanni; J. M. Barnett; M. L. Clark; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):3981.

ARVO Annual Meeting Abstract May 2008

The Influence of Age and OIR Disposition on the Angiostatic Effect of Penetrating Ocular Injury

W. Y. Boadi; G. W. McCollum; J. M. Barnett; A. S. Shah; K. M. Sharma; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2008; 49(13):521.

ARVO Annual Meeting Abstract May 2007

Inhibition of Retinal Neovascularization by Anecortave Acetate Through PAI-1 and Matrix Metalloproteinases

J. M. Barnett; M. N. Young; D. P. Bingaman; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):84.

ARVO Annual Meeting Abstract May 2007

COX-2 Promotes VEGF-Induced Angiogenesis in Retinal Endothelial Cells

M. L. Clark; Q. Song; J. M. Barnett; J. S. Penn

Invest. Ophthalmol. Vis. Sci.. 2007; 48(13):1722.

Retinal Cell Biology February 2007

Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR

PDF

Joshua M. Barnett; Gary W. McCollum; Jessica A. Fowler; James J.-W. Duan; Jesse D. Kay; Rui-Qin Liu; David P. Bingaman; John S. Penn
TAGS: gelatinase a, genetic manipulation, pharmacology, rats, retinal neovascularization, oxygen, intravitreal injections, mice, matrix metalloproteinase inhibitors, rodentia
Invest. Ophthalmol. Vis. Sci.. 2007; 48(2):907-915. https://doi.org/10.1167/iovs.06-0082

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Taurocholic acid prevents progression of age-related macular degeneration in in vitro models

Endoglin Promotes Angiogenesis in Cell- and Animal-Based Models of Retinal Neovascularization

Unlocking the Potential to Regenerate Lost Neurons and Visual Function

Blocking Endoglin Reduces Endothelial Progenitor Cell Angiogenic Capacity and Retinal Neovascularization

Tube Formation and Proliferative Capacities of Endothelial Progenitor Cell Subpopulations: a Systematic Analysis

Targeted Nanocarriers for Therapy of Ocular Neovascularization

In vitro Parallel Plate Flow Chamber Assessment of Endothelial Progenitor Cell Homing

Hyperglycemia Increases PGI2, VEGF and PPARβ/-Dependent Transcription in the Mouse Retina

Inhibition of Prostaglandins is Associated With Decreased Retinal VEGF Expression Levels in an Animal Model of AMD

Role of Cytosolic Phospholipase A 2 in Retinal Neovascularization

The Role of PGE 2 Receptor EP 4 in Pathologic Ocular Angiogenesis

A Validated Method of Analyzing Treatment Response of Choroidal Neovascularization using Adobe Photoshop

Inhibition of Retinal Vascular Growth and Development in PPARβ-/- Mice

Differential Gene Expression in Response to Penetrating Ocular Injury

The Influence of Penetrating Ocular Injury on Laser-Induced Choroidal Neovascularization in the Rat

PGE2 Receptor EP4 Is a Potential Therapeutic Target for the Treatment of Pathological Ocular Angiogenesis

The Influence of Age and OIR Disposition on the Angiostatic Effect of Penetrating Ocular Injury

Inhibition of Retinal Neovascularization by Anecortave Acetate Through PAI-1 and Matrix Metalloproteinases

COX-2 Promotes VEGF-Induced Angiogenesis in Retinal Endothelial Cells

Pharmacologic and Genetic Manipulation of MMP-2 and -9 Affects Retinal Neovascularization in Rodent Models of OIR

To View More...

You must be signed into an individual account to use this feature.